v3.25.2
Net Loss Per Share Attributable to Common Shareholders - Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Numerator:    
Net loss attributable to Kestra Medical Technologies, Ltd. $ (113,814) $ (94,120)
Undeclared preferred dividends (12,321) (6,721)
Net loss attributable to common shareholders, basic (126,135) (100,841)
Net loss attributable to common shareholders, diluted $ (126,135) $ (100,841)
Denominator:    
Weighted average shares of common shares outstanding, basic [1] 24,583,745 19,885,382
Weighted average shares of common shares outstanding, diluted [1] 24,583,745 19,885,382
Net loss per share attributable to common stockholder    
Net loss per share attributable to common shareholders, basic $ (5.13) $ (5.07)
Net loss per share attributable to common shareholders, diluted $ (5.13) $ (5.07)
[1]

1Weighted-average shares of common shares outstanding, basic and diluted, has been adjusted on a retrospective basis. Refer to Note 16 “Net Loss Per Share Attributable to Common Shareholders” for additional disclosure.